Taken together, these results suggest that candesartan-mediated normalization of intracellular Ca2+ homeostasis may translate into enhanced insulin signaling and improved systemic metabolism and overall metabolic health in the setting of obesity. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.